Damon Reed
Researcher
Deparment of Drug Discovery
Moffitt Cancer Center
United States of America
Biography
Dr. Damon Reed is affiliated to Deparment of Drug Discovery, Moffitt Cancer Center. Dr. Damon Reed is currently providing services as Researcher. Dr. Damon Reed has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Damon Reed contributions have acclaimed recognition from honourable subject experts around the world. Dr. Damon Reed is actively associated with different societies and academies. Dr. Damon Reed academic career is decorated with several reputed awards and funding. Dr. Damon Reed research interests include on the prediction of conventional chemotherapy efficacy in non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) using ex vivo assays and xenograft models.
Research Interest
On the prediction of conventional chemotherapy efficacy in non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) using ex vivo assays and xenograft models
Publications
-
Biermann JS, Chow W, Reed DR, Lucas D, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, Didwania A. NCCN Guidelines Insights: Bone Cancer, Version 2.2017. Journal of the National Comprehensive Cancer Network. 2017 Feb 1;15(2):155-67.
-
Reed DR, Hayashi M, Wagner L, Binitie O, Steppan DA, Brohl AS, Shinohara ET, Bridge JA, Loeb DM, Borinstein SC, Isakoff MS. Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer. 2017 Mar 1.
-
LaRosa KN, Stern M, Bleck J, Lynn C, Hudson J, Reed DR, Quinn GP, Donovan KA. Adolescent and Young Adult Patients with Cancer: Perceptions of Care. Journal of Adolescent and Young Adult Oncology. 2017 May 24.
